This paper is in the following e-collection/theme issue:

Patient-Reported Outcome Measures (PROMs) (275) Chemotherapy and Side Effects Management (52) Skin Cancer and Melanoma Prevention (110)

Published on in Vol 22, No 4 (2020): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/14896, first published .
Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Authors of this article:

Lærke K Tolstrup1, 2 Author Orcid Image ;   Helle Pappot3 Author Orcid Image ;   Lars Bastholt1, 2 Author Orcid Image ;   Ann-Dorthe Zwisler1, 4 Author Orcid Image ;   Karin B Dieperink1, 2 Author Orcid Image
Article Authors Cited by (22) Tweetations (15) Metrics

Lærke K Tolstrup   1, 2 * , MA, RNC ;   Helle Pappot   3 * , MD, PhD, Prof Dr ;   Lars Bastholt   1, 2 * , MD ;   Ann-Dorthe Zwisler   1, 4 * , MD, PhD, Prof Dr ;   Karin B Dieperink   1, 2 * , RNC, PhD

1 Department of Clinical Research, University of Southern Denmark, Odense, Denmark

2 Department of Oncology, Odense University Hospital, Odense, Denmark

3 Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark

4 The Danish Knowledge Centre for Rehabilitation and Palliative Care, Nyborg, Denmark

*all authors contributed equally

Corresponding Author:

  • Lærke K Tolstrup, MA, RNC
  • Department of Clinical Research
  • University of Southern Denmark
  • Sønder Boulevard 29
  • Odense, 5000
  • Denmark
  • Phone: 45 40295129
  • Email: laerke.tolstrup@rsyd.dk